July 2025

Pakistan’s pharmaceutical industry has achieved a historic milestone, with pharmaceutical exports soaring by 34% in the fiscal year 2024-2025 (FY25) — the highest growth recorded in over 20 years. According to data released by the Pakistan Pharmaceutical Manufacturers’ Association (PPMA), the country’s pharma exports reached $457 million, up from $341 million in FY24. This remarkable […]

Pakistan Pharma continues to expand its global reach through key strategic partnerships that benefit both local industry and international markets. In a progressive move to deepen international collaboration, the Pakistan Pharmaceutical Manufacturer Association (PPMA) welcomed the establishment of the Pakistan–UK Business Advisory Council. This forum is set to enhance bilateral trade in pharmaceuticals and healthcare,

PPMA Leadership, led by key executive members, held a productive meeting with DRAP Additional Director Dr. Obaid Ali to discuss regulatory reforms, industry challenges, and future collaboration to uplift Pakistan’s pharmaceutical sector. This strategic meeting marks a significant development in the ongoing efforts to strengthen regulatory coordination in the pharma industry of Pakistan. With the

PPMA appreciates the Finance Minister’s recognition and remains committed to strengthening public–private partnerships for a healthier, self-reliant Pakistan.

The Pakistan Pharmaceutical Industry is uniquely positioned to address this national pain point. With promising reforms, digital transformation, and investment support, the industry is on a strong growth path. Public-private partnerships and research-driven models offer new hope for both patients and producers. Moreover, the Pakistan Pharmaceutical Manufacturers Association (PPMA) serves as a key body in